Zarif K. Jabbar‐Lopez

机构：Galderma (Switzerland) · ORCID：0000-0003-4127-8263

发表论文 46 篇 · 总被引 1144 次 · h-index 15

代表论文

• Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis (2024 · JAMA Dermatology · 被引 59)
• Epidemiology of prurigo nodularis in England: a retrospective database analysis (2022 · British Journal of Dermatology · 被引 43)
• The effect of water hardness on atopic eczema, skin barrier function: A systematic review, meta‐analysis (2020 · Clinical & Experimental Allergy · 被引 41)
• Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents (2022 · Dermatology and Therapy · 被引 37)
• Longitudinal analysis of the effect of water hardness on atopic eczema: evidence for gene–environment interaction (2019 · British Journal of Dermatology · 被引 31)
• Randomized controlled pilot trial with ion‐exchange water softeners to prevent eczema (SOFTER trial) (2021 · Clinical & Experimental Allergy · 被引 20)